BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 32759670)

  • 1. Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (TWEAK) Enhances Activation of STAT3/NLRC4 Inflammasome Signaling Axis through PKCδ in Astrocytes: Implications for Parkinson's Disease.
    Samidurai M; Tarale P; Janarthanam C; Estrada CG; Gordon R; Zenitsky G; Jin H; Anantharam V; Kanthasamy AG; Kanthasamy A
    Cells; 2020 Aug; 9(8):. PubMed ID: 32759670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
    Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
    Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TWEAK-Fn14 Axis Induces Calcium-Associated Autophagy and Cell Death To Control Mycobacterial Survival in Macrophages.
    Chen YM; Liu PY; Tang KT; Liu HJ; Liao TL
    Microbiol Spectr; 2022 Dec; 10(6):e0317222. PubMed ID: 36321903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vanadium induces dopaminergic neurotoxicity via protein kinase Cdelta dependent oxidative signaling mechanisms: relevance to etiopathogenesis of Parkinson's disease.
    Afeseh Ngwa H; Kanthasamy A; Anantharam V; Song C; Witte T; Houk R; Kanthasamy AG
    Toxicol Appl Pharmacol; 2009 Oct; 240(2):273-85. PubMed ID: 19646462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TWEAK/Fn14 mediates atrial-derived HL-1 myocytes hypertrophy via JAK2/STAT3 signalling pathway.
    Hao L; Ren M; Rong B; Xie F; Lin MJ; Zhao YC; Yue X; Han WQ; Zhong JQ
    J Cell Mol Med; 2018 Sep; 22(9):4344-4353. PubMed ID: 29971943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TWEAK/Fn14 promotes oxidative stress through AMPK/PGC‑1α/MnSOD signaling pathway in endothelial cells.
    Liu H; Peng H; Xiang H; Guo L; Chen R; Zhao S; Chen W; Chen P; Lu H; Chen S
    Mol Med Rep; 2018 Jan; 17(1):1998-2004. PubMed ID: 29257217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TWEAK/Fn14 promotes pro-inflammatory cytokine secretion in hepatic stellate cells via NF-κB/STAT3 pathways.
    Wang A; Zhang F; Xu H; Xu M; Cao Y; Wang C; Xu Y; Su M; Zhang M; Zhuge Y
    Mol Immunol; 2017 Jul; 87():67-75. PubMed ID: 28411440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA Snhg3 contributes to dysfunction of cerebral microvascular cells in intracerebral hemorrhage rats by activating the TWEAK/Fn14/STAT3 pathway.
    Zhang J; Dong B; Hao J; Yi S; Cai W; Luo Z
    Life Sci; 2019 Nov; 237():116929. PubMed ID: 31610210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The TNF-like weak inducer of the apoptosis/fibroblast growth factor-inducible molecule 14 axis mediates histamine and platelet-activating factor-induced subcutaneous vascular leakage and anaphylactic shock.
    Mendez-Barbero N; Yuste-Montalvo A; Nuñez-Borque E; Jensen BM; Gutiérrez-Muñoz C; Tome-Amat J; Garrido-Arandia M; Díaz-Perales A; Ballesteros-Martinez C; Laguna JJ; Beitia JM; Poulsen LK; Cuesta-Herranz J; Blanco-Colio LM; Esteban V
    J Allergy Clin Immunol; 2020 Feb; 145(2):583-596.e6. PubMed ID: 31679818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of TWEAK/Fn14 signaling in the MPTP-model of Parkinson's disease.
    Mustafa S; Martin HL; Burkly L; Costa A; Martins ML; Schwaninger M; Teismann P
    Neuroscience; 2016 Apr; 319():116-22. PubMed ID: 26808775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor-like weak inducer of apoptosis induces inflammation in Graves' orbital fibroblasts.
    Lee SJ; Kim J; Ko J; Lee EJ; Koh HJ; Yoon JS
    PLoS One; 2018; 13(12):e0209583. PubMed ID: 30576385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteolytic activation of proapoptotic kinase protein kinase Cδ by tumor necrosis factor α death receptor signaling in dopaminergic neurons during neuroinflammation.
    Gordon R; Anantharam V; Kanthasamy AG; Kanthasamy A
    J Neuroinflammation; 2012 Apr; 9():82. PubMed ID: 22540228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental atopic dermatitis is dependent on the TWEAK/Fn14 signaling pathway.
    Liu Q; Wang H; Wang X; Lu M; Tan X; Peng L; Tan F; Xiao T; Xiao S; Xia Y
    Clin Exp Immunol; 2020 Jan; 199(1):56-67. PubMed ID: 31515807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of NLRC4 is critical for inflammasome activation.
    Qu Y; Misaghi S; Izrael-Tomasevic A; Newton K; Gilmour LL; Lamkanfi M; Louie S; Kayagaki N; Liu J; Kömüves L; Cupp JE; Arnott D; Monack D; Dixit VM
    Nature; 2012 Oct; 490(7421):539-42. PubMed ID: 22885697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor Necrosis Factor (TNF) Receptor Expression Determines Keratinocyte Fate upon Stimulation with TNF-Like Weak Inducer of Apoptosis.
    Wang X; Cheng D; Hu G; Liang L; Tan F; Xiao T; Xiao S; Xia Y
    Mediators Inflamm; 2019; 2019():2945083. PubMed ID: 31885495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TWEAK/Fn14 interaction induces proliferation and migration in human airway smooth muscle cells via activating the NF-κB pathway.
    Zhu C; Zhang L; Liu Z; Li C; Bai Y
    J Cell Biochem; 2018 Apr; 119(4):3528-3536. PubMed ID: 29143982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shigella type III secretion protein MxiI is recognized by Naip2 to induce Nlrc4 inflammasome activation independently of Pkcδ.
    Suzuki S; Franchi L; He Y; Muñoz-Planillo R; Mimuro H; Suzuki T; Sasakawa C; Núñez G
    PLoS Pathog; 2014 Feb; 10(2):e1003926. PubMed ID: 24516390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of anti-dsDNA ameliorates systemic lupus erythematosus in MRL/Faslpr mice through ameliorating inflammation via the PKCδ-NLRC4 axis.
    Yang F; Yang Y; Zeng W
    Biochem Cell Biol; 2021 Jun; 99(3):313-321. PubMed ID: 33064961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic neurotoxicant 6-OHDA induces oxidative damage through proteolytic activation of PKCδ in cell culture and animal models of Parkinson's disease.
    Latchoumycandane C; Anantharam V; Jin H; Kanthasamy A; Kanthasamy A
    Toxicol Appl Pharmacol; 2011 Nov; 256(3):314-23. PubMed ID: 21846476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathomechanism Characterization and Potential Therapeutics Identification for Parkinson's Disease Targeting Neuroinflammation.
    Chen CM; Yen CY; Chen WL; Lin CH; Wu YR; Chang KH; Lee-Chen GJ
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33494411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.